HDAC9 and acute myeloid leukemia: Since both DZNep and HDAC inhibitors are known to inhibit cell cycle progression [14,19], we analyzed the effect of the epigenetic agents alone and in combination on the cell cycle of the HL-60 and AML-3 leukemic cells by flow cytometry (Figure 3).